药物对比
Canagliflozin vs Glyburide
比较Canagliflozin（Invokana）与Glyburide（Glynase）治疗2型糖尿病。回顾SGLT2抑制剂与磺脲类的机制、获益、风险及适用性。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when patients on a sulfonylurea seek an SGLT2 inhibitor for added heart-kidney benefits or reduced hypoglycemia risk.
结论
Canagliflozin is generally preferred for patients with cardiovascular or renal disease, while Glyburide remains a low-cost option for uncomplicated glycemic control.
全部药物对比